Auddia Inc. (NASDAQ: AUUD) today highlighted Influence Healthcare, a healthtech company that leverages artificial intelligence and vertical integration to empower surgeons to lead adoption of value-based care (VBC) across surgical specialties. The announcement comes as Auddia intends to file its Form S-4 with the Securities and Exchange Commission later this week, a key step in the merger process that will combine Auddia with Thramann Holdings LLC to form McCarthy Finney.
Influence Healthcare is designed as a structural alternative to hospital employment and private-equity rollups, two models that often reduce physician autonomy or prioritize financial engineering over clinical leadership. The company organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments in spine, total joints, and other high-spend specialties. These VBEs are supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics.
“Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care,” said Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare. “Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price. Influence Healthcare is aimed at leveraging AI to minimize administrative noise so that physicians and all the other healthcare professionals with hands on patients are empowered to deliver the highest value care.”
Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney to deploy agentic-AI workflows that automate clinical documentation, coding and billing preparation, episode-of-care validation, prior-authorization workflows, care-pathway adherence monitoring, and communication across the episode. These workflows are designed to eliminate the administrative layers that have historically required multiple full-time administrative staff per surgeon and contributed to burnout and inefficiency.
“AI should not replace physicians, it should replace the administrative friction that prevents physicians from practicing at the top of their license,” Dr. Thramann said. “Our platform gives surgeons the environment they need to deliver a more predictable, coordinated, efficient, and compassionate episode of care.”
Influence Healthcare’s model is built on episode-of-care design, not practice acquisition. It integrates surgeon leadership, facility partners (ASCs, hospitals, imaging centers), post-acute providers, AI-enabled care coordination, and episode-based financial alignment. This creates a cohesive, end-to-end specialty care model without requiring surgeons to sell their practices or surrender governance.
The company’s initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs. For more information, visit www.influencehealthcare.com.
The merger, announced on February 17, 2026, will combine Auddia with Thramann Holdings, which owns LT350, Influence Healthcare, and Voyex. Upon completion, Auddia will change its name to McCarthy Finney and trade under the ticker MCFN. The S-4 filing is expected later this week, providing further details on the transaction.